LT

Lou Tartaglia

Managing Partner and Co-Founder at Cure Ventures

Greater Boston

Investor
VC
Founder

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biotechnology
Lifesciences
Technology Transfer
Commercialization
Pharmaceutical Industry
Drug Discovery
Venture Capital
Start-ups
Oncology
Medical Devices
Biopharmaceuticals
Clinical Development
R&D
Licensing
Immunology
Molecular Biology
Corporate Development
Mergers
Due Diligence
Biochemistry

Education

Lists including Lou

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Ablexis

Series A

Total Funding: $12M

Work Experience

Cure Ventures

2021

  • Managing Partner and Co-Founder

    2021

5AM Ventures

2016 - 2020

  • Venture Partner

    2018 - 2020

  • Head of 4:59

    2016 - 2018

Solstice Biologics

2014 - 2015

  • CEO

    2014 - 2015

TR
Third Rock Ventures

2007 - 2014

  • Partner

    2007 - 2014

GL
Gene Logic

2004 - 2007

  • General Manager

    2004 - 2007

MP
Millennium Pharmaceuticals

1993 - 2004

  • VP Metabolic Diseases

    1993 - 2004

G
Genentech

1990 - 1993

  • Postdoc

    1990 - 1993